Lipopeptide antifungal agents: Amine conjugates of the semi-synthetic pneumocandins L-731,373 and L-733,560
Data up to Jan 2025
Total Citations Per Year
Abstract
References (12)
Lipid Formulations of Amphotericin B: Recent Progress and Future Directions
1996 • 400 citations
RECENT PROGRESS AND CURRENT PROBLEMS IN TREATMENT OF INVASIVE FUNGAL INFECTIONS IN NEUTROPENIC PATIENTS
1996 • 127 citations
The Future of Antifungal Therapy
1996 • 110 citations
Synthesis and Antifungal Activity of Novel Cationic Pneumocandin Bo Derivatives
1994 • 109 citations
In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin
1992 • 94 citations
Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis
1995 • 80 citations
Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species.
1992 • 58 citations
In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373
1995 • 52 citations
Section Review: Anti-infectives: Lipopeptide antifungal agents
1994 • 51 citations
New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat
1995 • 44 citations
Recent Advances in the Medicinal Chemistry of Antifungal Agents
1996 • 23 citations
Antifungal lipopeptides: Structure-activity relationships of 3-hydroxyglutamine-modified pneumocandin B0 derivatives
1995 • 6 citations